Transmutex SA, a nuclear engineering company based in Geneva, Switzerland, raised over CHF 20m in the extension of its Series A funding to further develop its pivotal solution to a safer, lower-cost, proliferation-resistant nuclear energy
Transmutex SA, a nuclear engineering company based in Geneva, Switzerland, raised over CHF 20m in the extension of its Series A funding to further develop its pivotal solution to a safer, lower-cost, proliferation-resistant nuclear energy